NPM1 and breast carcinoma: Perturbation of protein tyrosine kinase signaling results in malignant transformation, as seen in ErbB2/HER2/Neu overexpression in breast cancer and the NPM-ALK fusion gene in anaplastic large cell lymphoma [87,88].